Sanofi
SNY
$48.66
$0.310.64%
NASDAQ
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | 6.95% | -15.16% | |
| Total Other Revenue | -- | -- | -1.47% | 31.02% | |
| Total Revenue | -- | -- | 6.29% | -12.40% | |
| Cost of Revenue | -- | -- | 2.88% | -12.86% | |
| Gross Profit | -- | -- | 7.81% | -12.20% | |
| SG&A Expenses | -- | -- | 1.08% | -26.92% | |
| Depreciation & Amortization | -- | -- | -10.04% | -21.43% | |
| Other Operating Expenses | -- | -- | -8.99% | 38.29% | |
| Total Operating Expenses | -- | -- | 2.06% | -10.35% | |
| Operating Income | -- | -- | 26.27% | -20.60% | |
| Income Before Tax | -- | -- | 9.23% | -57.60% | |
| Income Tax Expenses | -- | -- | 17.21% | -63.63% | |
| Earnings from Continuing Operations | -- | -- | 7.63% | -56.16% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -59.43% | 53.73% | |
| Net Income | -- | -- | 1.61% | -49.69% | |
| EBIT | -- | -- | 26.27% | -20.60% | |
| EBITDA | -- | -- | 25.23% | -16.32% | |
| EPS Basic | -- | -- | 1.60% | -49.69% | |
| Normalized Basic EPS | -- | -- | -- | -- | |
| EPS Diluted | -- | -- | 1.50% | -49.76% | |
| Normalized Diluted EPS | -- | -- | -- | -- | |
| Average Basic Shares Outstanding | -- | -- | -0.04% | -0.08% | |
| Average Diluted Shares Outstanding | -- | -- | 0.04% | 0.10% | |
| Dividend Per Share | -- | -- | 3.23% | 11.29% | |
| Payout Ratio | -- | -- | -- | -- | |